David A Mankoff

发表

Choosing a single target as a biomarker or therapeutic using radioactive probes.

William C Eckelman, David A Mankoff, D. Mankoff, 2015, Nuclear medicine and biology.

Quantitative assessment of dynamic PET imaging data in cancer imaging.

Paul E Kinahan, Finbarr O'Sullivan, Larry A Pierce, 2012, Magnetic resonance imaging.

PennPET Explorer: Human Imaging on a Whole-Body Imager

Joel S Karp, Gerd Muehllehner, Margaret E Daube-Witherspoon, 2019, The Journal of Nuclear Medicine.

Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.

Mark Muzi, Finbarr O'Sullivan, David A Mankoff, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.

David A Mankoff, Alexander M Spence, Kenneth A Krohn, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The Value of Establishing the Quantitative Accuracy of PET/CT Imaging

Paul E Kinahan, David A Mankoff, Hannah M Linden, 2015, The Journal of Nuclear Medicine.

Kinetic Analysis of 18F-Fluoride PET Images of Breast Cancer Bone Metastases

Mark Muzi, David A Mankoff, Robert K Doot, 2010, Journal of Nuclear Medicine.

18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy.

Mark Muzi, Satoshi Minoshima, David A Mankoff, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Invasive breast cancer.

Richard Zellars, Andres Forero, David A Mankoff, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond

Mark Muzi, David A Mankoff, Janet F Eary, 2007, Clinical Cancer Research.

Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Joel Karp, A. D. Van den Abbeele, Daniel Sullivan, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A definition of molecular imaging.

David A Mankoff, D. Mankoff, 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

True tracers: comparing FDG with glucose and FLT with thymidine.

Mark Muzi, David A Mankoff, Alexander M Spence, 2005, Nuclear medicine and biology.

[F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: clinical outcomes and patterns of failure.

Mark Muzi, David A Mankoff, Alexander M Spence, 2006, International journal of radiation oncology, biology, physics.

Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer.

Mark Muzi, Hubert Vesselle, David A Mankoff, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A Phase II Study of 3′-Deoxy-3′-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688

Fenghai Duan, Mark Muzi, Linda Hovanessian-Larsen, 2015, The Journal of Nuclear Medicine.

Association between serial dynamic contrast‐enhanced MRI and dynamic 18F‐FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer

Xiaoyu Chai, David A Mankoff, Brenda F Kurland, 2010, Journal of magnetic resonance imaging : JMRI.

Current and future uses of positron emission tomography in breast cancer imaging.

David A Mankoff, D. Mankoff, W. Eubank, 2004, Seminars in nuclear medicine.

Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

Bruce D Cheson, David A Mankoff, Daniel C Sullivan, 2005, Clinical Cancer Research.

Tumor Receptor Imaging

David A Mankoff, Kenneth A Krohn, Hannah M Linden, 2008, Journal of Nuclear Medicine.

PET imaging of cellular proliferation.

David A Mankoff, Kenneth A Krohn, D. Mankoff, 2005, Radiologic clinics of North America.

Positron emission tomography imaging of brain tumors.

Mark Muzi, David A Mankoff, Alexander M Spence, 2003, Neuroimaging clinics of North America.

How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.

David A Mankoff, D. Mankoff, A. Clark, 2015, JAMA oncology.

Quantitative positron emission tomography imaging to measure tumor response to therapy: what is the best method?

Mark Muzi, David A Mankoff, Kenneth A Krohn, 2003, Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging.

Evolving role of positron emission tomography in breast cancer imaging.

David A Mankoff, D. Mankoff, W. Eubank, 2005, Seminars in nuclear medicine.

Molecular Imaging Research in the Outcomes Era: Measuring Outcomes for Individualized Cancer Therapy 1 Most of Cancer Imaging Thus Far Has Been Directed To- Ward Cancer Detection and Staging. the Principle Guiding

Finbarr O'Sullivan, David A Mankoff, Kenneth A Krohn, 2022 .

FDG PET, PET/CT, and breast cancer imaging.

David A Mankoff, D. Mankoff, W. Eubank, 2007, Radiographics : a review publication of the Radiological Society of North America, Inc.

A Virtual Clinical Trial of FDG-PET Imaging of Breast Cancer: Effect of Variability on Response Assessment.

Paul E Kinahan, Thomas K Lewellen, David A Mankoff, 2014, Translational oncology.

18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.

Thomas K Lewellen, Kristin Swanson, Mark Muzi, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

ACR Appropriateness Criteria Breast Cancer Screening.

David A Mankoff, Mary C Mahoney, Handel E. Reynolds, 2013, Journal of the American College of Radiology : JACR.

ACR Appropriateness Criteria Breast Cancer Screening.

David A Mankoff, Mary C Mahoney, Handel E. Reynolds, 2016, Journal of the American College of Radiology : JACR.

Accuracy of CT-based attenuation correction in PET/CT bone imaging

Manuel Desco, Paul E Kinahan, Adam M Alessio, 2012, Physics in medicine and biology.

Letter to cancer center directors: Progress in quantitative imaging as a means to predict and/or measure tumor response in cancer therapy trials.

Paul E Kinahan, Thomas E Yankeelov, John M Buatti, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Kinetic modeling of 3'-deoxy-3'-fluorothymidine in somatic tumors: mathematical studies.

Mark Muzi, Hubert Vesselle, David A Mankoff, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Repeatability of 18F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma

Martin A Lodge, Jeffrey P Leal, David A Mankoff, 2017, The Journal of Nuclear Medicine.

Dynamic and Static Approaches to Quantifying 18F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF

Paul E Kinahan, Mark Muzi, David A Mankoff, 2007, Journal of Nuclear Medicine.

Residual tumor uptake of [99mTc]‐sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival

Robert B Livingston, David A Mankoff, Hannah M Linden, 2005, Cancer.

Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.

Robert B Livingston, David A Mankoff, D. Mankoff, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Modulation of P-glycoprotein at the Human Blood-Brain Barrier by Quinidine or Rifampin Treatment: A Positron Emission Tomography Imaging Study

David A Mankoff, Janet F Eary, Jashvant D Unadkat, 2015, Drug Metabolism and Disposition.

Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy.

Robert B Livingston, David A Mankoff, Hannah M Linden, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

How Imaging Can Impact Clinical Trial Design: Molecular Imaging as a Biomarker for Targeted Cancer Therapy

David A Mankoff, Daniel A Pryma, D. Mankoff, 2015, Cancer journal.